COVID-19 has recently created a public health emergency and has been declared a pandemic by the World Health Organization. There are serious concerns regarding surge capacity of UK facilities to cope with a pandemic illness and it is conceivable that the psychological, emotional and physical demands placed on an already overstretched workforce may be substantial.
The CERA study aims to understand the evolving and cumulative effects of working during the COVID-19 outbreak on the psychological health of those physicians working in the emergency care settings across the UK. Physicians will be asked to complete questionnaires on their phones at 3 different time scales; during the Acceleration phase (beginning), during the Peak phase (middle) and during the Deceleration phase (end). It is anticipated that this study will enhance future pandemic preparedness, by highlighting staff resilience and tolerance, and where further support – delivered either during or after an incident – may be beneficial.
The study itself is a TERN project with the support of EMERGE.
The purpose of this study is to test a new vaccine, ChAdOx1 nCoV-19, against COVID-19 in healthy volunteers.
The ChAdOx1 nCoV-19 vaccine has been developed in Oxford in an effort to protect healthy people from the pandemic. This study will evaluate the safety of the vaccine and its ability to generate an immune response against the virus.
This is a randomised trial. Participants will be randomly allocated to receive either the ChAdOx1 nCoV-19 vaccine, or a Men ACWY (meningitus vaccine). Volunteers will not be told which vaccine they will receive.
Participants will be asked to return for 6 visits across 12 months to evaluate their health.
Across the UK the trial aims to recruit 10,260 volunteers.
If you are interested in taking part, please click on this link and complete the online questionnaire: https://www.covid19vaccinetrial.co.uk/participate-edinburgh
The purpose of this study is to test a new vaccine against COVID-19 in healthy volunteers.